Journal
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
Volume 20, Issue 5, Pages 497-530Publisher
HARBORSIDE PRESS
DOI: 10.6004/jnccn.2022.0025
Keywords
-
Categories
Ask authors/readers for more resources
This passage introduces the recommended management for non-small cell lung cancer (NSCLC) in the NCCN Clinical Practice Guidelines, with a focus on targeted therapies for patients with metastatic NSCLC and actionable mutations.
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non???Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, pri -mary treatment, surveillance for relapse, and subsequent treat-ment. Patients with metastatic lung cancer who are eligible for targeted therapies or immunotherapies are now surviving longer. This selection from the NCCN Guidelines for NSCLC focuses on targeted therapies for patients with metastatic NSCLC and action-able mutations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available